E. Metcalfe Et Al. , "CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy," Journal of Cancer Research and Therapeutics , vol.14, no.6, pp.1373-1378, 2018
Metcalfe, E. Et Al. 2018. CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy. Journal of Cancer Research and Therapeutics , vol.14, no.6 , 1373-1378.
Metcalfe, E., ARIK, D., ÖGE, T., ETİZ, D., YALÇIN, Ö. T., Kabukcuoglu, S., ... Pasaoglu, O.(2018). CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy. Journal of Cancer Research and Therapeutics , vol.14, no.6, 1373-1378.
Metcalfe, Evrim Et Al. "CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy," Journal of Cancer Research and Therapeutics , vol.14, no.6, 1373-1378, 2018
Metcalfe, Evrim Et Al. "CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy." Journal of Cancer Research and Therapeutics , vol.14, no.6, pp.1373-1378, 2018
Metcalfe, E. Et Al. (2018) . "CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy." Journal of Cancer Research and Therapeutics , vol.14, no.6, pp.1373-1378.
@article{article, author={Evrim METCALFE Et Al. }, title={CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy}, journal={Journal of Cancer Research and Therapeutics}, year=2018, pages={1373-1378} }